BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4954419)

  • 21. Once-daily ethosuximide in the treatment of absence epilepsy.
    Dooley JM; Camfield PR; Camfield CS; Fraser AD
    Pediatr Neurol; 1990; 6(1):38-9. PubMed ID: 2106890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethosuximide in childhood absence epilepsy--older and better.
    Vining EP
    N Engl J Med; 2010 Mar; 362(9):843-5. PubMed ID: 20200390
    [No Abstract]   [Full Text] [Related]  

  • 23. ZARONTIN (ETHOSUXIMIDE) IN THE TREATMENT OF PETIT MAL AND RELATED DISORDERS.
    KIORBOE E; PALUDAN J; TROLLE E; OVERVAD E
    Epilepsia; 1964 Mar; 5():83-9. PubMed ID: 14155209
    [No Abstract]   [Full Text] [Related]  

  • 24. A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine.
    Posner EB; Mohamed K; Marson AG
    Seizure; 2005 Mar; 14(2):117-22. PubMed ID: 15694565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethosuximide-induced de novo systemic lupus erythematosus with anti-double-strand DNA antibodies: a case report with definite evidence.
    Crespel A; Velizarova R; Agullo M; Gélisse P
    Epilepsia; 2009 Aug; 50(8):2003. PubMed ID: 19682032
    [No Abstract]   [Full Text] [Related]  

  • 26. [Does antiabsence drug ethosuximide exert antidepressant effect?].
    Sarkisova KIu; Kulikov MA; Folomkina AA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2011; 61(2):227-35. PubMed ID: 21675229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticonvulsants specific for petit mal antagonize epileptogenic effect of leucine enkephalin.
    Snead OC; Bearden LJ
    Science; 1980 Nov; 210(4473):1031-3. PubMed ID: 6254150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood serotonin in untreated petit-mal epileptics and influence of efficient treatment with either ethosuximide or valproate.
    Volanschi D; Luca N; Haţegan D; Ionescu G
    Neurol Psychiatr (Bucur); 1982; 20(1):67-70. PubMed ID: 6803347
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of control in typical childhood absence epilepsy.
    Desai J; Mitchell WG
    J Child Neurol; 2013 May; 28(5):678-9. PubMed ID: 23529908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New methods of seizure treatment in epilepsy].
    Tchicaloff M
    Munch Med Wochenschr; 1965 Nov; 107(45):2249-52. PubMed ID: 4957660
    [No Abstract]   [Full Text] [Related]  

  • 31. An older drug for childhood absence epilepsy.
    Potera C
    Am J Nurs; 2010 Jun; 110(6):16. PubMed ID: 20505447
    [No Abstract]   [Full Text] [Related]  

  • 32. ETHOSUXIMIDE (ALPHA-ETHYL-ALPHA-METHYLSUCCINIMIDE) AND GRAND MAL.
    LORENTZDEHAAS AM; KUILMAN M
    Epilepsia; 1964 Mar; 5():90-6. PubMed ID: 14155210
    [No Abstract]   [Full Text] [Related]  

  • 33. [ZARONTIN THERAPY OF PETIT MAL EPILEPSY RESISTANT TO ANTICONVULSANTS].
    PROT J; SAPER J; STROINSKA B
    Neurol Neurochir Psychiatr Pol; 1963; 13():487-90. PubMed ID: 14079934
    [No Abstract]   [Full Text] [Related]  

  • 34. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Posner EB; Mohamed K; Marson AG
    Cochrane Database Syst Rev; 2003; (3):CD003032. PubMed ID: 12917940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical trials with ethosuximide (Zarontin) in therapy-resistant epileptics].
    Sato T; Kondo Y; Matsuo T; Iwata H; Okuyama Y; Aoki Y
    No To Shinkei; 1965 Sep; 17(9):958-64. PubMed ID: 4953431
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in erythrocyte water content in subjects with "petit mal" epilepsy after treatment with alpha-ethyl-alpha-methyl-succinimide].
    Cassarino P; Falsaperla A; Papalia G
    Acta Neurol (Napoli); 1969; 24(3):416-30. PubMed ID: 4993840
    [No Abstract]   [Full Text] [Related]  

  • 37. Blockade of "antiabsence" activity of sodium valproate by THIP in rats with petit mal-like seizures. Comparison with ethosuximide.
    Vergnes M; Marescaux C; Micheletti G; Rumbach L; Warter JM
    J Neural Transm; 1985; 63(2):133-41. PubMed ID: 3930659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is ethosuximide a risk factor for generalised tonic-clonic seizures in absence epilepsy?
    Schmitt B; Kovacevic-Preradovic T; Critelli H; Molinari L
    Neuropediatrics; 2007 Apr; 38(2):83-7. PubMed ID: 17712736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ethosuximide in the treatment of oxazolidineresistant petit mal epilepsy].
    HERRLIN KM
    Nord Med; 1963 Mar; 69():336-8. PubMed ID: 13954083
    [No Abstract]   [Full Text] [Related]  

  • 40. Absence seizures in children.
    Posner E
    Clin Evid; 2003 Dec; (10):295-300. PubMed ID: 15555093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.